Cargando…

IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis

IKKα has been shown to be responsible of multiple pro-tumorigenic functions and therapy resistance independent of canonical NF-κB, but its role in acquired chemotherapy resistance in breast cancer remains unclarified. In this study, we obtained pre-treatment biopsy and post-treatment mastectomy spec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Jian, Qin, Qing-hong, Lv, Fa-you, Huang, Zhen, Lian, Bin, Wei, Chang-yuan, Mo, Qin-guo, Tan, Qi-xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110611/ https://www.ncbi.nlm.nih.gov/pubmed/37069240 http://dx.doi.org/10.1038/s41598-023-33358-x

Ejemplares similares

Inhibiting 4E-BP1 re-activation represses podocyte cell cycle re-entry and apoptosis induced by adriamycin
por: Li, Fang, et al.
Publicado: (2019)

Platinum-based chemotherapy in triple-negative breast cancer: A meta-analysis
por: LIU, MIAO, et al.
Publicado: (2013)

PARP inhibitor re-sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis
por: Wu, Jie, et al.
Publicado: (2019)

Astragalus Polysaccharide Promotes Adriamycin-Induced Apoptosis in Gastric Cancer Cells
por: Song, Jie, et al.
Publicado: (2020)

IKKα negatively regulates ASC-dependent inflammasome activation
por: Martin, Bradley N., et al.
Publicado: (2014)

Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model
por: Hong, Young Mi, et al.
Publicado: (2017)

Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy
por: Xie, Kewei, et al.
Publicado: (2019)

MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4
por: Wang, Guang-Chao, et al.
Publicado: (2016)

CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis
por: Wang, Depeng, et al.
Publicado: (2023)

Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
por: Sun, Wenxia, et al.
Publicado: (2013)

CircRNA_0044556 diminishes the sensitivity of triple-negative breast cancer cells to adriamycin by sponging miR-145 and regulating NRAS
por: Chen, Jingjing, et al.
Publicado: (2022)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
por: Lv, Yufei, et al.
Publicado: (2021)

Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy
por: Uddin, Mohammad M., et al.
Publicado: (2018)

NBDHEX re‐sensitizes adriamycin‐resistant breast cancer by inhibiting glutathione S‐transferase pi
por: Sha, Huanhuan, et al.
Publicado: (2022)

Cross-talk between ER stress and mitochondrial pathway mediated adriamycin-induced testicular toxicity and DA-9401 modulate adriamycin-induced apoptosis in Sprague–Dawley rats
por: Karna, Keshab Kumar, et al.
Publicado: (2019)

PIWIL2 interacting with IKK to regulate autophagy and apoptosis in esophageal squamous cell carcinoma
por: Zhao, Xu, et al.
Publicado: (2021)

IKKα and IKKβ Regulation of DNA Damage-Induced Cleavage of Huntingtin
por: Khoshnan, Ali, et al.
Publicado: (2009)

Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
por: Kim, Hyeon A, et al.
Publicado: (2023)

Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016)

Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer
por: Zhang, Xiangyang, et al.
Publicado: (2022)

Transcriptional repression of IKKβ by p53 in arsenite-induced GADD45α accumulation and apoptosis
por: Hu, Yongliang, et al.
Publicado: (2018)

The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis
por: Li, Zhi-Wei, et al.
Publicado: (1999)

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2016)

Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
por: Perren, T. J., et al.
Publicado: (1990)

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma.
por: Carmo-Pereira, J., et al.
Publicado: (1987)

Selective degradation of IKKα by autophagy is essential for arsenite-induced cancer cell apoptosis
por: Tan, Qixing, et al.
Publicado: (2020)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020)

USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin
por: Qin, Tao, et al.
Publicado: (2021)

Renoprotective Effect of Plantago major Against Proteinuria and Apoptosis Induced by Adriamycin in Rat
por: Yazd, Zohreh Naji Ebrahimi, et al.
Publicado: (2019)

CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
por: Gao, Jian, et al.
Publicado: (2018)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Xia, Bingqing, et al.
Publicado: (2021)

Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways
por: Hossain, Fokhrul, et al.
Publicado: (2018)

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation
por: HE, MIAO, et al.
Publicado: (2013)

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation
por: He, Miao, et al.
Publicado: (2022)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Effects of Adriamycin-Cytoxan chemotherapy on hematological and electrolyte parameters among breast cancer patients
por: Tadesse, Fikremariam Abiye, et al.
Publicado: (2023)

Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss
por: Ruocco, Maria Grazia, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_a9tspf9ta9nhsvqmpistjapha7